Cargando…
Quantitative ELISA-Like Immunohistochemistry of Fibroblast Growth Factor 23 in Diagnosis of Tumor-Induced Osteomalacia and Clinical Characteristics of the Disease
Tumor-induced osteomalacia (TIO) is a rare acquired paraneoplastic disorder and fibroblast growth factor 23 (FGF23) plays a key role in its pathogenesis. This study was conducted to describe a novel FGF23 detecting procedure and describe clinical features of the disease. Fourteen TIO cases were retr...
Autores principales: | Hu, Fangke, Jiang, Chengying, Zhang, Qiang, Shi, Huaiyin, Wei, Lixin, Wang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808528/ https://www.ncbi.nlm.nih.gov/pubmed/27034530 http://dx.doi.org/10.1155/2016/3176978 |
Ejemplares similares
-
Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022) -
Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
por: Westerberg, Per-Anton, et al.
Publicado: (2012) -
Tumor-induced osteomalacia with normal systemic fibroblast growth factor-23 level
por: Amblee, Ambika, et al.
Publicado: (2014) -
Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23
por: Lee, Ji-Yeon, et al.
Publicado: (2017) -
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)